Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amgen Inc Updates FY 2015 Guidance To A Range In Line With Analysts' Estimates-Conference Call

Thursday, 7 Feb 2013 01:00pm EST 

Amgen Inc updated guidance for fiscal 2015 with revenues of at least the upper end of $16 billion to $18 billion in adjusted EPS of at least $8 a share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $18 billion and EPS of $8.49 for fiscal 2015. 

Company Quote

0.63 +0.45%
1:48pm EDT